KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 98 filers reported holding KALVISTA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,831,273 | +6.0% | 605,532 | -0.9% | 1.81% | +20.6% |
| Q2 2023 | $5,499,288 | +13.6% | 611,032 | -0.8% | 1.50% | +3.6% |
| Q1 2023 | $4,842,012 | +16.3% | 616,032 | 0.0% | 1.45% | +23.8% |
| Q4 2022 | $4,164,376 | +12.4% | 616,032 | +141.3% | 1.17% | +17.8% |
| Q3 2022 | $3,705,000 | +41.7% | 255,313 | -3.9% | 1.00% | +39.9% |
| Q2 2022 | $2,614,000 | -7.0% | 265,663 | +39.3% | 0.71% | -2.7% |
| Q1 2022 | $2,810,000 | +11.4% | 190,663 | 0.0% | 0.73% | +15.5% |
| Q4 2021 | $2,522,000 | -23.6% | 190,663 | +0.8% | 0.63% | -27.6% |
| Q3 2021 | $3,301,000 | +127.3% | 189,163 | +212.2% | 0.88% | +188.2% |
| Q2 2021 | $1,452,000 | -3.5% | 60,600 | +3.4% | 0.30% | -14.8% |
| Q1 2021 | $1,505,000 | -42.5% | 58,600 | -71.8% | 0.36% | -58.0% |
| Q3 2020 | $2,619,000 | -2.7% | 208,054 | -6.5% | 0.85% | +9.5% |
| Q2 2020 | $2,692,000 | +49.8% | 222,452 | -5.3% | 0.78% | +3.6% |
| Q1 2020 | $1,797,000 | +308.4% | 234,952 | +850.3% | 0.75% | +396.7% |
| Q4 2019 | $440,000 | +53.3% | 24,725 | 0.0% | 0.15% | +39.8% |
| Q3 2019 | $287,000 | -47.6% | 24,725 | 0.0% | 0.11% | -47.6% |
| Q2 2019 | $548,000 | -17.6% | 24,725 | +6.5% | 0.21% | -28.2% |
| Q1 2019 | $665,000 | +66.7% | 23,225 | +14.8% | 0.29% | +44.9% |
| Q4 2018 | $399,000 | +1.8% | 20,225 | +14.1% | 0.20% | +23.0% |
| Q3 2018 | $392,000 | – | 17,725 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 719,937 | $6,697,459 | 5.56% |
| TCG Crossover Management, LLC | 3,395,495 | $22,953,546 | 4.05% |
| VR Adviser, LLC | 2,916,667 | $19,716,669 | 3.32% |
| TANG CAPITAL MANAGEMENT LLC | 3,196,446 | $21,607,975 | 3.14% |
| Prosight Management, LP | 621,667 | $4,202,469 | 2.29% |
| Opaleye Management Inc. | 923,200 | $6,240,832 | 2.17% |
| GREAT POINT PARTNERS LLC | 1,055,801 | $7,137,215 | 1.40% |
| Frazier Life Sciences Management, L.P. | 3,238,859 | $21,894,687 | 1.36% |
| DAFNA Capital Management LLC | 616,032 | $4,164,376 | 1.17% |
| Vivo Capital, LLC | 856,008 | $5,787 | 0.67% |